Perez-Segura P - Search Results

1

A breast cancer family from Spain with germline mutations in both the BRCA1 and BRCA2 genes.

Caldes T, de la Hoya M, Tosar A, Sulleiro S, Godino J, Ibañez D, Martin M, Perez-Segura P, Diaz-Rubio E. Caldes T, et al. J Med Genet. 2002 Aug;39(8):e44. doi: 10.1136/jmg.39.8.e44. J Med Genet. 2002. PMID: 12161611 Free PMC article. No abstract available.

2

Pre-test prediction models of BRCA1 or BRCA2 mutation in breast/ovarian families attending familial cancer clinics.

de la Hoya M, Díez O, Pérez-Segura P, Godino J, Fernández JM, Sanz J, Alonso C, Baiget M, Díaz-Rubio E, Caldés T. de la Hoya M, et al. J Med Genet. 2003 Jul;40(7):503-10. doi: 10.1136/jmg.40.7.503. J Med Genet. 2003. PMID: 12843322 Free PMC article.

3

Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.

de la Hoya M, Osorio A, Godino J, Sulleiro S, Tosar A, Perez-Segura P, Fernandez C, Rodríguez R, Díaz-Rubio E, Benítez J, Devilee P, Caldés T. de la Hoya M, et al. Int J Cancer. 2002 Feb 1;97(4):466-71. doi: 10.1002/ijc.1627. Int J Cancer. 2002. PMID: 11802208

4

Association between BRCA1 mutations and ratio of female to male births in offspring of families with breast cancer, ovarian cancer, or both.

de la Hoya M, Fernández JM, Tosar A, Godino J, Sánchez de Abajo A, Vidart JA, Pérez-Segura P, Díaz-Rubio E, Caldés T. de la Hoya M, et al. JAMA. 2003 Aug 20;290(7):929-31. doi: 10.1001/jama.290.7.929. JAMA. 2003. PMID: 12928470

5

Spanish family study on hereditary breast and/or ovarian cancer: analysis of the BRCA1 gene.

de la Hoya M, Pérez-Segura P, Van Orsouw N, Díaz-Rubio E, Caldés T. de la Hoya M, et al. Int J Cancer. 2001 Jan 1;91(1):137-40. doi: 10.1002/1097-0215(20010101)91:1<137::aid-ijc1020>3.0.co;2-r. Int J Cancer. 2001. PMID: 11149413 No abstract available.

6

Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain.

Caldes T, Godino J, de la Hoya M, Garcia Carbonero I, Perez Segura P, Eng C, Benito M, Diaz-Rubio E. Caldes T, et al. Int J Cancer. 2002 Apr 10;98(5):774-9. doi: 10.1002/ijc.10240. Int J Cancer. 2002. PMID: 11920650

7

A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families.

Romero A, Pérez-Segura P, Tosar A, García-Saenz JA, Díaz-Rubio E, Caldés T, de la Hoya M. Romero A, et al. Breast Cancer Res Treat. 2011 Oct;129(3):939-46. doi: 10.1007/s10549-011-1543-x. Epub 2011 May 3. Breast Cancer Res Treat. 2011. PMID: 21537932

8

Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families.

de Garibay GR, Díaz A, Gaviña B, Romero A, Garre P, Vega A, Blanco A, Tosar A, Díez O, Pérez-Segura P, Díaz-Rubio E, Caldés T, de la Hoya M. de Garibay GR, et al. Eur J Hum Genet. 2013 Aug;21(8):883-6. doi: 10.1038/ejhg.2012.268. Epub 2012 Dec 5. Eur J Hum Genet. 2013. PMID: 23211700 Free PMC article.

9

Low frequency of microsatellite instability in sporadic breast cancer.

Caldes T, Perez-Segura P, Tosar A, De La Hoya M, Diaz-Rubio E. Caldes T, et al. Int J Oncol. 2000 Jun;16(6):1235-42. doi: 10.3892/ijo.16.6.1235. Int J Oncol. 2000. PMID: 10812001

10

Microsatellite instability correlates with negative expression of estrogen and progesterone receptors in sporadic breast cancer.

Caldés T, Perez-Segura P, Tosar A, de La Hoya M, Diaz-Rubio E. Caldés T, et al. Teratog Carcinog Mutagen. 2000;20(5):283-91. Teratog Carcinog Mutagen. 2000. PMID: 10992275

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters